The two HPV vaccines that are available are HPV2 (Cervarix) and HPV9 (Gardasil 9). Subsidies are only available for HPV2 (Cervarix).

HPV2 (Cervarix) provides protection against HPV types 16 and 18, which account for 70% of all cervical cancers, and have been shown to be both clinically- and cost-effective in the local setting. It is registered for use for females.

HPV9 vaccination (Gardasil 9) provides protection against an additional 20% of cancer-causing HPV types. It is registered for use for both females and males.

Subsidies are not available for HPV9 (Gardasil 9).

Please confirm with your doctor on the type of HPV vaccination that you wish to receive prior when making the appointment. At present, only HPV2 (Cervarix) can be booked through the Health Appointment System.